Publication | Closed Access
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial
103
Citations
15
References
2020
Year
VaccinationVaccine SafetyVaccinologyVaccine DevelopmentVaccine TestingPediatricsVaccine EfficacyMedicineTetravalent Dengue Vaccine
| Year | Citations | |
|---|---|---|
Page 1
Page 1